Grown Rogue International (GRUSF) Total Debt Growth (1y) (2010 - 2025)
Grown Rogue International (GRUSF) Total Debt Growth (1y) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | -3.69% |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 37.49% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -2.48% |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 4.38% |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | -6.91% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 41.53% |
| 10 | Grown Rogue International | 110.47 Mn | 98.93 Mn | 5.37 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 922,180,181.77% |
| Apr 30, 2021 | 99.64% |
| Oct 31, 2020 | 433.21% |
| Jul 31, 2020 | 871.71% |
| Apr 30, 2020 | 1,070.38% |
| Oct 31, 2019 | 200.00% |
| Apr 30, 2019 | 0.00% |
| Oct 31, 2018 | -90.04% |
| May 31, 2018 | -55.65% |
| Feb 28, 2018 | 38.88% |
| Nov 30, 2015 | 91.80% |
| Aug 31, 2015 | -80.67% |
| May 31, 2015 | 32.17% |
| Feb 28, 2015 | -146.98% |
| Nov 30, 2014 | 40.86% |
| Aug 31, 2014 | 642.18% |
| May 31, 2014 | -169.88% |
| Feb 28, 2014 | -19.72% |
| Nov 30, 2013 | -25,947.81% |
| Aug 31, 2013 | 147.05% |